PHASE II PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF DOXORUBICIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE (ABVD) FOLLOWED BY RADIATION THERAPY (RT) VERSUS ABVD ALONE FOR STAGES I, II, AND IIIA HODGKIN LYMPHOMA WITH ROLE OF PROGNOSTIC BIOLOGICAL PARAMETERS
Wael Mahmoud Youssef;
Abstract
Background and Objectives: The optimal treatment of early-stage Hodgkin lymphoma has been controversial because of the success of several approaches. Concerns regarding radiation toxicities and the previously detected good response to chemotherapy have le
Other data
| Title | PHASE II PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF DOXORUBICIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE (ABVD) FOLLOWED BY RADIATION THERAPY (RT) VERSUS ABVD ALONE FOR STAGES I, II, AND IIIA HODGKIN LYMPHOMA WITH ROLE OF PROGNOSTIC BIOLOGICAL PARAMETERS | Other Titles | دراسة تجريبية اكلينيكية مقارنة لعلاج المراحل الأولى والثانية والثالثة أ من مرضى اورام الغدد الليمفاوية الهودجكين بالعلاج الكيميائي بعقارات الدوكسوروبسين والبليوميسين والفينبلاستين والداكاربازين يتبع بالعلاج الاشعاعي مقارنة بالعلاج الكيميائي فقط مع تقييم | Authors | Wael Mahmoud Youssef | Keywords | PHASE II PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF DOXORUBICIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE (ABVD) FOLLOWED BY RADIATION THERAPY (RT) VERSUS ABVD ALONE FOR STAGES I, II, AND IIIA HODGKIN LYMPHOMA WITH ROLE OF PROGNOSTIC BIOLOGICAL PARAMETERS | Issue Date | 2012 | Description | Background and Objectives: The optimal treatment of early-stage Hodgkin lymphoma has been controversial because of the success of several approaches. Concerns regarding radiation toxicities and the previously detected good response to chemotherapy have le |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 111441R7452.pdf | 452.13 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.